From Bedside to Boardroom: How AI, Multi-Omics, and New Business Models Are Shaping the Biomedical Frontier with Morgan Cheatham

In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Morgan Cheatham, a vice president at Bessemer Venture Partners and a medical student at Brown University, about his unique career path and perspectives on AI in healthcare. Cheatham discusses his background, which blends computational science with medicine, and shares insights on balancing his roles in venture capital and medical school. The conversation covers Cheatham's work on a paper assessing ChatGPT's performance on the USMLE, the challenges and opportunities in AI adoption within healthcare, and his investment thesis, which focuses on identifying and supporting AI-first companies. He also shares his vision for the future of medicine, emphasizing the importance of genomics and multiomics, and offers advice for aspiring medical students interested in technology and innovation.